✦ LIBER ✦

First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer

✍ Scribed by Athanassiou, AE; Bafaloukos, D; Pectasides, D; Dimitriadis, M; Varthalitis, I; Barbounis, V

Book ID: 109836269
Publisher: Nature Publishing Group
Year: 1989
Tongue: English
Weight: 618 KB
Volume: 60
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1989.353

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide, paclitaxel and cisplatin fir

Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer

✍ Christos A. Papadimitriou; Charalambos Kouroussis; Lia A. Moulopoulos; Georgios 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 1 views

## BACKGROUND. The combination of paclitaxel with a platinum analogue is the preferred chemotherapy regimen in the treatment of advanced epithelial ovarian carcinoma. The alkylating agent ifosfamide has shown activity in refractory or recurrent ovarian cancer. We conducted a Phase II study with th

First-line combination chemotherapy with

First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer

✍ P. Periti; G. Robustelli Delia Cuna; F. Pannuti; T. Mazzei; P. Preti; A. Martoni 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 312 KB

In this study, 30 evaluable patients with advanced carcinoma of the breast were treated with cyclophosphamide 600 mg/m2 i.v. followed one day later with mitoxantrone (Novantrone; dihydroxyanthracenedione) 16 mg/m2 i.v. Drug treatment was repeated every 3-4 weeks, for a maximum of 12 cycles. The over

Carboplatin/etoposide as first-line chem

Carboplatin/etoposide as first-line chemotherapy in advanced ovarian carcinoma: a pilot study

✍ Wolfgang Eiermann; Wolf Achterrath; Luigi Lenaz; Hermann Hepp 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 494 KB

Treatment of advanced ovarian cancer wit

Treatment of advanced ovarian cancer with sequential combination chemotherapy

✍ Thomas W. Griffin; Richard A. Hunter; Andrew I. Cederbaum; Won K. Tak; Allen D. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

Combination chemotherapy with epirubicin

Combination chemotherapy with epirubicin and cisplatin in ovarian carcinoma

✍ L. C. Fuith; A. Bazzanella; H. Hetzel 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 319 KB

Etoposide in combination as first-line c

Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A cancer and leukemia group B study

✍ Jeffrey J. Kirshner; James R. Anderson; Barbara Parker; Maurice Barcos; M. Rober 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB 👁 1 views

Background. In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease. Thirty-six evaluable patients were treated with two or three courses of methotrexate, vincristine, prednisone, leucovorin, etoposide, and cyclophos